Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ING2 | Q9H160 | 3/20 | 1.00 |
| ▸ | DUSP5 | Q16690 | 1/20 | 0.63 |
| ▸ | DUSP6 | Q16828 | 1/20 | 0.63 |
| ▸ | LCK | P06239 | 1/20 | 0.41 |
| ▸ | FYN | P06241 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 2/20 | 0.41 |
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | CA7 | P43166 | 2/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | PTPRB | P23467 | 1/20 | 0.41 |
| ▸ | CASP6 | P55212 | 3/20 | 0.40 |
| ▸ | NSD2 | O96028 | 2/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | PLCG1 | P19174 | 1/20 | 0.40 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | NT5E | P21589 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29776588 | 1.00 | ING2 (1.00) | ING2DUSP5DUSP6LCKFYN | |
| SCHEMBL29664959 | 1.00 | ING2 (1.00) | ING2DUSP5DUSP6LCKFYN | |
| SCHEMBL15397119 | 1.00 | ING2 (1.00) | ING2DUSP5DUSP6LCKFYN | |
| SCHEMBL15397115 | 1.00 | ING2 (1.00) | ING2DUSP5DUSP6LCKFYN | |
| SCHEMBL29486957 | 1.00 | ING2 (1.00) | ING2DUSP5DUSP6LCKFYN | |
| SCHEMBL29486958 | 1.00 | ING2 (1.00) | ING2DUSP5DUSP6LCKFYN | |
| Water SCHEMBL31084794 | 0.98 | ING2 (0.95) | ING2DUSP5DUSP6LCKFYN | |
| Water SCHEMBL30366794 | 0.98 | ING2 (0.95) | ING2DUSP5DUSP6LCKFYN | |
| SCHEMBL19196167 | 0.90 | ING2 (0.81) | ING2DUSP5DUSP6LCKFYN | |
| SCHEMBL22828087 | 0.90 | ING2 (0.81) | ING2DUSP5DUSP6LCKFYN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230225988-A1 | ANTIVIRAL USE OF CALIXARENES | CEBINA GmbH (AT) | 2023-07-20 | — | — | US | disclosed |
| US-20230225988-A1 | ANTIVIRAL USE OF CALIXARENES | CEBINA GmbH (AT) | 2023-07-20 | — | — | US | disclosed |
| US-11179358-B2 | Compound for use in the prevention and treatment of neurodegenerative diseases | Universität Wien (AT) | 2021-11-23 | — | — | US | disclosed |
| EP-3863613-A1 | MACROCYCLIC COMPOUNDS AND USES THEREOF | Aalto University Foundation (FI) | 2021-08-18 | — | — | EP | disclosed |
| US-20200360315-A1 | COMPOUND FOR USE IN THE PREVENTION AND TREATMENT OF NEURODEGENERATIVE DISEASES | Universität Wien (AT) | 2020-11-19 | — | — | US | disclosed |
| US-10246573-B2 | Anti-static compositions | HONEYWELL INTERNATIONAL INC. (US) | 2019-04-02 | — | — | US | disclosed |
| US-20170218179-A1 | ANTI-STATIC COMPOSITIONS | HONEYWELL SAFETY PRODUCTS USA, INC. | 2017-08-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200360315-A1 | COMPOUND FOR USE IN THE PREVENTION AND TREATMENT OF NEURODEGENERATIVE DISEASES | SNCA, PARK7, HTT | ING2 2759/4885DUSP5 2626/4885DUSP6 2762/4885 |
| US-11179358-B2 | Compound for use in the prevention and treatment of neurodegenerative diseases | SNCA, PARK7, HTT | ING2 2759/4885DUSP5 2626/4885DUSP6 2762/4885 |
| US-20230225988-A1 | ANTIVIRAL USE OF CALIXARENES | CALU, CANX, CTSA | ING2 4014/4885DUSP5 1815/4885DUSP6 1390/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.